Patents by Inventor Rosa María Hernández

Rosa María Hernández has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lipid nanoparticles for wound healing
    Patent number: 10206886
    Abstract: The present invention refers to lipid nanoparticles comprising a growth factor and/or an antimicrobial peptide and to the method for their preparation. Moreover, it refers to pharmaceutical compositions comprising such lipid nanoparticles, and a pharmaceutical acceptable carrier. Finally, it also refers to said pharmaceutical composition for its use as medicament and for its use in promoting wound healing, particularly by topical administration.
    Type: Grant
    Filed: July 3, 2014
    Date of Patent: February 19, 2019
    Assignee: PRAXIS BIOPHARMA RESEARCH INSTITUTE
    Inventors: Eusebio Gainza Lafuente, Garazi Gainza Lucea, Silvia Villullas Rincón, Marta Pastor Navarro, Oihane Ibarrola Moreno, Gorka Alonso Hornes, Angel Del Pozo Pérez, Rosa María Hernández Martín, Manuela Igartua Olaechea, José Luis Pedraz Muñoz
  • LIPID NANOPARTICLES FOR WOUND HEALING
    Publication number: 20160199447
    Abstract: The present invention refers to lipid nanoparticles comprising a growth factor and/or an antimicrobial peptide and to the method for their preparation. Moreover, it refers to pharmaceutical compositions comprising such lipid nanoparticles, and a pharmaceutical acceptable carrier. Finally, it also refers to said pharmaceutical composition for its use as medicament and for its use in promoting wound healing, particularly by topical administration.
    Type: Application
    Filed: July 3, 2014
    Publication date: July 14, 2016
    Inventors: Eusebio GAINZA LAFUENTE, Garazi GAINZA LUCEA, Silvia VILLULLAS RINCÓN, Marta PASTOR NAVARRO, Oihane IBARROLA MORENO, Gorka ALONSO HORNES, Angel DEL POZO PÉREZ, Rosa, María HERNÁNDEZ MARTÍN, Manuela IGARTUA OLAECHEA, José, Luis PEDRAZ MUÑOZ
  • Biodegradable Bionanoparticles for Releasing the GSE24-2 Peptide, Method for the Production Thereof, and Use of Same
    Publication number: 20160051485
    Abstract: The invention relates to biodegradable PLGA bionanoparticles encapsulating the GSE24-2 peptide with telomerase activity and to pharmaceutical, cosmetic and biotechnological compositions comprising same. The pharmaceutical compositions are useful for treating diseases presenting a telomerase deficiency, such as dyskeratosis congenita, and diseases presenting ageing characteristics, such as Werner syndrome, Rothmund Thompson syndrome, and other diseases where there is DNA damage such as ataxia telangiectasia. The invention likewise relates to the method for producing said bionanoparticles by means of a w/o/w double emulsion technique.
    Type: Application
    Filed: February 3, 2014
    Publication date: February 25, 2016
    Inventors: Rosario Perona Abellon, Jose Luis Pedraz Munoz, Rosa Maria Hernandez Martin, Manuela Igartua Olaechea, Susana Eguskiaguirre Martin, Cristina Manguan Garcia
  • Semi-solid mucoadhesive formulations
    Patent number: 8663688
    Abstract: Semisolid mucoadhesive formulations for vaginal application, with improved technical and organoleptic characteristics, which contain at least two bioadhesive gelling polymers and an active ingredient, useful in the prevention and/or treatment of various pathologies and disorders in human beings or animals.
    Type: Grant
    Filed: July 16, 2004
    Date of Patent: March 4, 2014
    Assignee: ITF Research Pharma, S.L.U.
    Inventors: Álvaro Acebrón Fernández, Ana Campuzano Garcia, Rosa Maria Hernández Martin, Manuela Igatúa Olaechea, José Luis Pedraz Muñoz, Alicia Rodriguez Gascón
  • USE OF MICROPARTICLES CONTAINING GENETICALLY MODIFIED CELLS IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
    Publication number: 20110212060
    Abstract: The present invention relates to methods for the treatment of neurodegenerative diseases by means of the use of microparticles comprising genetically modified cells expressing neurotrophic and/or angiogenic factors and wherein said microparticles are administered by means of implantation at the cerebral cortex level.
    Type: Application
    Filed: July 23, 2009
    Publication date: September 1, 2011
    Applicants: UNIVERSIDAD DEL PAIS VASCO
    Inventors: Rosa María Hernández Martín, Gorka Orive Arroyo, Carlos Spuch Calvar, Desiree Antequera Tienda, Félix Bermejo-Pareja, Eva Carro Díaz, José Luis Pedraz Muñoz
  • USE OF MICROPARTICLES FOR VACCINES AND THE RELEASE OF BIOLOGICALLY ACTIVE MOLECULES
    Publication number: 20100297192
    Abstract: The invention relates to microparticles based on a PLGA biodegradable polymer and an alginate polymer which encapsulate immunologically active peptides or proteins. Said microparticles, and the pharmaceutical compositions developed from them and the uses thereof, are applicable to the field of human and animal health as a vaccine and system for releasing biologically active molecules.
    Type: Application
    Filed: November 14, 2008
    Publication date: November 25, 2010
    Applicant: UNIVERSIDAD DEL PAIS VASCO
    Inventors: Rosa Maria Hernandez Martin, Manuela Igartua Olaechea, Jose Luis Pedraz Munoz
  • RGD-MODIFIED ALGINATE MICROPARTICLES AS A DRUG RELEASE SYSTEM
    Publication number: 20100272812
    Abstract: The object of the present invention is to provide particles of a polymeric material containing cells therein, wherein said particles have a strength that is substantially greater than the microcapsules known in the state of the art.
    Type: Application
    Filed: June 25, 2008
    Publication date: October 28, 2010
    Applicant: UNIVERSIDAD DEL PAIS VASCO
    Inventors: Gorka Orive Arroyo, José Luis Pedraz Muñoz, Rosa María Hernández